Advocacy Actions
Meeting with National Medical Products Administration (NMPA)
On 25th December, EUCCC cosmetics WG chair Janice Ma and manager June Yu had a meeting with the Vice Commissioner Jiangying Yan, Director General of Cosmetics Department Jinju Li, Deputy Director General of Cosmetics department Liubin Qi from NMPA and Vice President Lu Yong from NIFDC, and heads of China Food and Drug Regulatory Data Center, the First and Second Department of Drug Supervision and Administration.
Read moreComments to the National Medical Products Administration (NMPA) on Measures on Administration and Supervision of Toothpaste
On 12th December 2020, the Cosmetics Working Group submitted the comments to NMPA upon Measures on Administration and Supervision of Toothpaste regarding articles with different opinions from member companies.
Read moreCosmetic Avdisory Committee Annual Meeting 2020 with National Medical Products Administration (NMPA) and National Institutes for Food and Drug Control (NIDFC)
Cosmetic Avdisory Committee Annual Meeting 2020 with National Medical Products Administration (NMPA) and National Institutes for Food and Drug Control (NIDFC) discussed CSAR secondary legislations drafting and implementation
Read moreComments to the National Medical Products Administration (NMPA) on Document Requirements for Cosmetic Product Registrations and Notifications, Document Requirements for New Ingredient Registrations and Notifications, and Document Requirements for Guidelin
On 30th November 2020, the Cosmetics Working Group submitted comments to NMPA upon Document Requirements for Cosmetic Product Registrations and Notifications, Document Requirements for New Ingredient Registrations and Notifications, and Document Requirements for Guidelines for the Evaluation of Cosmetic Efficacy Claims regarding articles with different opinions from member companies.
Read moreRoundtable with MOFCOM Official on European Business Operations in China
Roundtable with MOFCOM Official on European Business Operations in China
Read moreComments to the National Medical Products Administration (NMPA) on Standards for Cosmetics Production Quality, Administrative Measures for Cosmetics Adverse Effect Monitoring, and Management Regulations for Cosmetic Sampling Inspection
On 15th September 2020, the Cosmetics Working Group submitted the comments to NMPA upon Standards for Cosmetics Production Quality, Administrative Measures for Cosmetics Adverse Effect Monitoring, and Management Regulations for Cosmetic Sampling Inspection regarding articles with different opinions from member companies.
Read moreComments to the National Medical Products Administration (NMPA) on Document requirements for Guidelines for the Evaluation of Cosmetic Efficacy Claims
On 17th Sept 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Document requirements for Guidelines for the Evaluation of Cosmetic Efficacy Claims regarding articles with different opinions from member companies.
Read moreComments to the National Medical Products Administration (NMPA) on Document Requirements for Cosmetic Product Registrations and Notifications and Document Requirements for New Ingredient Registrations and Notifications
On 15th September 2020, the Cosmetics Working Group submitted the comments to NMPA upon Document Requirements for Cosmetic Product Registrations and Notifications and Document Requirements for New Ingredient Registrations and Notifications regarding articles with different opinions from member companies.
Read moreComments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)
The European Chamber submitted collated comments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)
Read moreSubmitted Comments to the National Medical Products Administration (NMPA) on the Product Safety Assessment Guidelines
On 28th August 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Product Safety Assessment Guidelines regarding articles with different opinions from member companies.
Read more